Open original FDA record ↗Recall record
- FDA identifier
- Z-1248-2019
- Company in FDA record
- Baxter Healthcare Corporation
- FDA record creation date
- May 2, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The flow rate test verification was not properly executed for certain Sigma Spectrum infusion pumps prior to release. The testing was performed for less than the required minimum run time. Improperly performed flow rate testing may not identify issues with pumps that could cause inaccuracies in flow rates which, in turn, could lead to over- or under- infusion. Potential risk to the patient depends on a number of factors including treatment and patient comorbidities. Depending on these factors, the patient could experience serious adverse health consequences.
Source facts
- Action
- On June 22, 2018, the firm notified customers by sending out an Urgent Medical Device Correction letter via USPS first class mail. Users were provided with affected serial numbers specific to their site, and informed that flow rate testing had not been properly executed on the identified devices. The firm is requesting the return of all affected devices to ensure proper testing is performed. ***Actions to be taken by Customers*** 1. Locate all affected pumps at your facility. 2. Return the device to Baxter for testing. To arrange for return of affected devices, contact Baxter Healthcare Medina at 800-356-3454 between the hours of 7:00 am and 7:00 pm Eastern Time, Monday through Friday. Please have your Baxter 8-digit ship-to account number, product code, serial number, and quantity of devices to be returned ready when calling. 3. If you purchased this product directly from Baxter, complete the enclosed Baxter Customer Reply Form and return it to Baxter by faxing it to 224-270-5457 or scanning and e-mailing it to fca@baxter.com, even if you do not have any inventory. Returning the customer reply form promptly will confirm your receipt of this notification and prevent you from receiving repeat notices. 4. If you purchased this product from a distributor, please note that the Baxter customer reply form is not applicable. If a reply form is provided by your distributor or wholesaler, please return it to the supplier according to their instructions. 5. If you distribute this product to other facilities or departments within your institution, please forward a copy of this communication to them. 6. If you are a dealer, wholesaler, distributor/reseller, or original equipment manufacturer (OEM) that distributed any affected product to other facilities, please notify your customers of this Urgent Medical Device Correction in accordance with your customary procedures. If you have additional questions, please contact your Baxter sales rep
- Initiated
- 2018-06-21
- Root cause
- Process control
- Terminated
- 2019-05-23
- Distribution
- US Nationwide distribution in the states of AL, AZ, CA, CT, DE, FL, FA, HI, IL, IN, KY, LA, MA, MD, MI, MN, MO, MS, NC, NJ, NM, NV, NY, OH, OK, OR, PA, RI, TN, TX, VA, VT, WA, and WI.
- Recall number
- Z-1248-2019
- Recall status
- Terminated
- CDRH record ID
- 165249
- FDA record created
- 2019-05-02
- Recall event number
- 80355